Regulatory Filings • Apr 23, 2024
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 23 April 2024 15:56
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Redcare Pharmacy N.V. / Key word(s): Regulatory Approval
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
23-Apr-2024 / 15:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using their electronic health card and their mobile phone.
The eHealth-CardLink solution is expected to be available in Redcare Pharmacy´s German Shop Apotheke app by early May.
Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: [email protected]
End of Inside Information
23-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 – 200 800 300 |
| Fax: | 0800 – 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1887349 |
| End of Announcement | EQS News Service |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.